Leucogen Suspension for Injection for Cats

국가: 영국

언어: 영어

출처: VMD (Veterinary Medicines Directorate)

유효 성분:

Feline leukemia virus

제공처:

Virbac

ATC 코드:

QI06AA01

INN (International Name):

Feline leukemia virus

약제 형태:

Suspension for injection

처방전 유형:

POM-V - Prescription Only Medicine – Veterinarian

치료 그룹:

Cats

치료 영역:

Inactivated Viral Vaccine

승인 상태:

Authorized

승인 날짜:

2009-06-17

제품 특성 요약

Issued: September 2023
AN: 00161/2023
Page 1 of 5
SUMMARY OF PRODUCT CHARACTERISTICS
1.
NAME OF THE VETERINARY MEDICINAL PRODUCT
LEUCOGEN suspension for injection for cats
2.
QUALITATIVE AND QUANTITATIVE COMPOSITION
Per dose of 1 ml:
ACTIVE SUBSTANCE:
Minimum quantity of purified p45 FeLV-envelope antigen
102 µg
ADJUVANTS:
3% aluminium hydroxide gel expressed as mg Al
3+
1 mg
Purified extract of _Quillaja saponaria_
10 µg
EXCIPIENTS:
Buffered isotonic solution to
1 ml.
For the full list of excipients, see section 6.1.
3.
PHARMACEUTICAL FORM
Suspension for injection.
Opalescent liquid.
4.
CLINICAL PARTICULARS
4.1
TARGET SPECIES
Cats
4.2
INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES
Active immunisation of cats from eight weeks of age against feline
leukaemia for the
prevention of persistent viraemia and clinical signs of the related
disease.
The onset of immunity has been demonstrated from 3 weeks after the
primary
vaccination.
After the primary vaccination course, the duration of immunity lasts
for one year.
Following a first booster vaccination one year after the primary
vaccination course, a
duration of immunity of 3 years has been demonstrated.
4.3
CONTRAINDICATIONS
None.
Issued: September 2023
AN: 00161/2023
Page 2 of 5
4.4
SPECIAL WARNINGS FOR EACH TARGET SPECIES
Vaccinate healthy animals only.
4.5
SPECIAL PRECAUTIONS FOR USE
Special precautions for use in animals
De-worming at least 10 days prior to vaccination is recommended.
Only feline leukaemia virus (FeLV) negative cats should be vaccinated.
Therefore, a
test for presence of FeLV before vaccination is recommended.
Special precautions to be taken by the person administering the
veterinary medicinal
product to animals
In case of accidental self-injection, seek medical advice immediately
and show the
package leaflet or the label to the physician.
4.6
ADVERSE REACTIONS (FREQUENCY AND SERIOUSNESS)
A moderate and transient local reaction (<2 cm) is commonly observed
after the first
injection. This local reaction could be a swelling, an oedema or a
nodu